BONAZZETTI, CECILIA MARIA
 Distribuzione geografica
Continente #
AS - Asia 2.343
NA - Nord America 1.085
EU - Europa 928
SA - Sud America 131
AF - Africa 75
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.583
Nazione #
US - Stati Uniti d'America 1.044
CN - Cina 647
VN - Vietnam 569
SG - Singapore 564
IT - Italia 550
HK - Hong Kong 149
KR - Corea 135
BR - Brasile 91
BD - Bangladesh 78
IN - India 61
DE - Germania 59
FR - Francia 51
NL - Olanda 51
JP - Giappone 46
GB - Regno Unito 42
CI - Costa d'Avorio 41
RU - Federazione Russa 32
FI - Finlandia 30
CA - Canada 24
IE - Irlanda 24
AR - Argentina 23
AT - Austria 20
AU - Australia 17
SE - Svezia 16
ZA - Sudafrica 15
IQ - Iraq 14
TW - Taiwan 13
TH - Thailandia 12
ID - Indonesia 11
PL - Polonia 11
PH - Filippine 10
ES - Italia 8
MX - Messico 8
BG - Bulgaria 7
TR - Turchia 7
JO - Giordania 6
PK - Pakistan 6
SA - Arabia Saudita 6
UA - Ucraina 5
CH - Svizzera 4
CO - Colombia 4
EC - Ecuador 4
PY - Paraguay 4
SC - Seychelles 4
BE - Belgio 3
CL - Cile 3
DK - Danimarca 3
LT - Lituania 3
NI - Nicaragua 3
TN - Tunisia 3
AL - Albania 2
CY - Cipro 2
EG - Egitto 2
JM - Giamaica 2
MA - Marocco 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
DZ - Algeria 1
ET - Etiopia 1
FJ - Figi 1
GD - Grenada 1
GH - Ghana 1
GR - Grecia 1
HN - Honduras 1
KE - Kenya 1
MK - Macedonia 1
MU - Mauritius 1
NA - Namibia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PG - Papua Nuova Guinea 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
VE - Venezuela 1
VI - Stati Uniti Isole Vergini 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
Totale 4.583
Città #
Singapore 412
Hefei 313
Ashburn 187
Ho Chi Minh City 167
Bologna 138
Hong Kong 129
Seoul 128
San Jose 123
Hanoi 120
Dallas 89
Santa Clara 68
Milan 56
New York 55
Boardman 46
Council Bluffs 45
Abidjan 41
Los Angeles 41
Beijing 40
Tokyo 39
Bengaluru 34
Da Nang 29
Castel Maggiore 26
Lauterbourg 25
Rome 25
Dublin 23
São Paulo 23
Buffalo 22
Haiphong 16
Vienna 15
Frankfurt am Main 14
Munich 14
Can Tho 13
Boydton 12
Helsinki 12
Modena 12
Johannesburg 11
Lappeenranta 11
Nuremberg 11
Redondo Beach 11
Turin 11
Adelaide 10
Florence 10
Quận Bình Thạnh 10
Amsterdam 9
Chicago 9
Shanghai 9
Catania 8
Genoa 8
London 8
Montreal 8
Rimini 8
Tongling 8
Toronto 8
Warsaw 8
Bến Tre 7
Cesena 7
Guangzhou 7
Hải Dương 7
Paris 7
Sofia 7
Thái Nguyên 7
Turku 7
Amman 6
Atlanta 6
Bangkok 6
Chandler 6
Denver 6
Ha Long 6
Jakarta 6
Naples 6
Orem 6
The Dalles 6
Verona 6
Berlin 5
Buenos Aires 5
Bắc Ninh 5
City of London 5
Falkenstein 5
Hyderabad 5
Palermo 5
Pavia 5
Secaucus 5
Baghdad 4
Bari 4
Bhubaneswar 4
Biên Hòa 4
Budrio 4
Cagliari 4
Catanzaro 4
Ferrara 4
Jeddah 4
Lunano 4
Miami 4
Moscow 4
Mumbai 4
Nanjing 4
Ninh Bình 4
Nizhniy Novgorod 4
Salt Lake City 4
San Francisco 4
Totale 2.967
Nome #
Artificial Intelligence model to predict resistances in Gram-negative bloodstream infections 294
Relationship between immune response to SARS-CoV2 vaccines and development of breakthrough infection in solid organ transplant recipients: the CONTRAST cohort 254
Epidemiological characteristics and management of Gram-negative bacteraemia in different immunocompromised hosts: Observational single-center study 211
Impact of attaining an aggressive PK/PD target with continuous infusion beta-lactams on the clinical efficacy of targeted therapy of early post-transplant Gram-negative infections in critically ill OLT recipients. An interim analysis of a 3-year prospective, observational, study 209
Exploring parvovirus B19 pathogenesis and therapy among kidney transplant recipients: case report and review of literature 198
Risk factors associated with bacteremia in COVID-19 patients admitted to intensive care unit: a retrospective multicenter cohort study 188
A pre-post quasi-experimental study of antimicrobial stewardship exploring the impact of a multidisciplinary approach aimed at attaining an aggressive joint pharmacokinetic/pharmacodynamic target with ceftazidime/avibactam on treatment outcome of KPC-producing Klebsiella pneumoniae infections and on ceftazidime/avibactam resistance development 187
Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort 185
Tolerability of pulsed high-dose L-AmB as pre-emptive therapy in patients at high risk for intra-abdominal candidiasis: A phase 2 study (LAMBDA study) 178
Real-Time TDM-Guided Optimal Joint PK/PD Target Attainment of Continuous Infusion Piperacillin–Tazobactam Monotherapy Is an Effective Carbapenem-Sparing Strategy for Treating Non-Severe ESBL-Producing Enterobacterales Secondary Bloodstream Infections: Findings from a Prospective Pilot Study 178
Validation of the INCREMENT-SOT-CPE score in a large cohort of liver transplant recipients with carbapenem-resistant Enterobacterales infection 176
Comparison between available early antiviral treatments in outpatients with SARS-CoV-2 infection: a real-life study 174
COVID-19 clinical phenotypes in vaccinated and nonvaccinated solid organ transplant recipients: a multicenter validation study 165
Enterococcus faecium bacteraemia: a multicentre observational study focused on risk factors for clinical and microbiological outcomes 164
A pre-post quasi-experimental study of the impact of TDM-guided aggressive pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftolozane/tazobactam monotherapy in treating severe Pseudomonas aeruginosa infections: A strategy useful for raising the bar? 154
Could an optimized joint pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftazidime-avibactam be a way to avoid the need for combo therapy in the targeted treatment of deep-seated DTR Gram-negative infections? 153
Using machine learning to predict antibody response to SARS-CoV-2 vaccination in solid organ transplant recipients: the multicentre ORCHESTRA cohort 152
Long-term immune response after SARS-CoV2 vaccination in solid organ transplant recipients 142
Clinical outcome in solid organ transplant recipients affected by COVID-19 compared to general population: a systematic review and meta-analysis 137
Effect of a Fourth Dose of mRNA Vaccine and of Immunosuppression in Preventing SARS-CoV-2 Breakthrough Infections in Heart Transplant Patients 134
The impact of preservation fluid culture on graft site arteritis: a systematic review and metanalysis 128
Impact on clinical outcome of follow-up blood cultures and risk factors for persistent bacteraemia in patients with gram-negative bloodstream infections: a systematic review with meta-analysis 115
Survey on the approach to antibiotic prophylaxis in liver and kidney transplant recipients colonized with “difficult to treat” Gram‐negative bacteria 103
Association of Patients’ Epidemiological Characteristics and Comorbidities with Severity and Related Mortality Risk of SARS-CoV-2 Infection: Results of an Umbrella Systematic Review and Meta-Analysis 97
HHV8-related diseases in solid organ transplantation: a case series and systematic literature review 96
Comparison between available early antiviral treatments in outpatients with SARS-CoV-2 infection: a real-life study 94
ORCHESTRA Delphi consensus: diagnostic and therapeutic management of SARS-CoV-2 infection in haematological patients 92
Implementation of a Bundle for the Management of Patients With Gram-Negative Bloodstream Infection: A Pre-Post Quasi-experimental Study 62
Pan-European Fragile Populations Cohort for COVID-19: What Worked, What Didn't, and Lessons Learned 58
The controversial bond between COVID-19 and bacterial superinfections 51
ORCHESTRA Delphi consensus: diagnostic and therapeutic management of SARS-CoV-2 infection in patients with rheumatological diseases 48
From clinical trials to daily practice: How to adequately administer sulbactam-durlobactam? alone or combined with imipenem? 43
Impact of HCV eradication with direct-acting antiviral agents on serum gamma globulin levels in HCV and HCV/HIV coinfected patients 36
Aggressive joint pharmacokinetic/pharmacodynamic target attainment of TDM-guided continuous infusion meropenem-vaborbactam monotherapy: a valuable strategy for maximizing the microbiological outcome of documented KPC-producing Enterobacterales infections? 34
Totale 4.690
Categoria #
all - tutte 10.755
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.755


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202221 0 0 0 0 0 0 0 0 4 7 6 4
2022/2023104 3 5 1 3 25 7 1 7 27 5 11 9
2023/2024213 14 11 7 10 12 19 13 23 16 38 22 28
2024/2025864 31 65 52 63 82 31 44 50 27 67 139 213
2025/20263.488 310 493 342 324 216 93 352 123 549 226 233 227
Totale 4.690